Slowing the Degenerative Process, Long Lasting Effect of Hyperbaric Oxygen Therapy in Retinitis Pigmentosa

NCT00461435 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL

Last updated 2007-04-18

No results posted yet for this study

Summary

Our aim was to assess the role and usefulness of Hyperbaric oxygen therapy in a long lasting period, assessing its efficacy on rescuing retinal photoreceptors and preserving visual function in retinitis pigmentosa.

Conditions

Interventions

PROCEDURE

hyperbaric oxygen therapy

Sponsors & Collaborators

  • Azienda Policlinico Umberto I

    lead OTHER

Principal Investigators

  • Enzo Maria Vingolo, PH.D. · Policlinico Umberto I, Dipartimento di Oftalmologia

Study Design

Allocation
RANDOMIZED
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
20 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Countries

  • Italy

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00461435 on ClinicalTrials.gov